Benzinga | Jan 27, 2021 05:49PM EST

Taro Pharmaceutical Indus Q3 EPS $0.86 Misses $1.01 Estimate, Sales $140.10M Miss $152.63M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.86 per share which missed the analyst consensus estimate of $1.01 by 14.85 percent. This is a 51.14 percent decrease over earnings of $1.76 per share from the same period last year. The company reported quarterly sales of $140.10 million which missed the analyst consensus estimate of $152.63 million by 8.21 percent. This is a 5.13 percent decrease over sales of $147.68 million the same period last year.